News
InterShunt Technologies announced today that it began an early feasibility study of its device for reducing heart failure symptoms.
2d
Medical Device Network on MSNInterShunt initiates study of device for heart failure treatmentInterShunt Technologies has initiated the EASE HF2 early feasibility study to assess the InterShunt percutaneous atrial shunt ...
1d
All Penny Stocks (English) on MSNShares of Micro Cap Biotech Jump as New Law Opens Florida to Company’s Stem Cell TreatmentsStem cell therapies are gradually becoming a viable medical option for a range of health conditions. Today, a micro-cap ...
David Mays, a cancer survivor, is dying — but he's at peace with his fate because he’s got friends, love and support.
Heart transplantation remains the optimal long-term treatment for appropriate patients with advanced heart failure. However, the donor heart shortage is a limiting factor, and the risk profile of ...
Drug Absorption in the Management of Congestive Heart Failure: Loop Diuretics Domenic A. Sica, MD Disclosures CHF. 2003;9 (5) Systemic Absorption ...
Sarfez Pharmaceuticals, founded by Indian American Salim Shah, received FDA approval for its Soaanz drug, which treats patients suffering from heart failure and renal disease. (ascthem.com photo ...
If you've received a diagnosis of heart failure, your doctor may recommend you change your diet to help manage the condition. Learn about meal plans and making healthy food choices for heart failure.
Centene's Guidance Withdrawal Spooks Sector, Oscar Health Stock Falls Trump-Administration's Health Agency Overstepped Authority, Reorganization Unlawful: Court Obama Warns 16 Million Americans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results